REQUEST A DEMO
Total
USD $0.00
Search more companies

Optimapharm S.R.O. (Czech Republic)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Optimapharm S.R.O. Profile Updated: November 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Optimapharm S.R.O. is based in Czech Republic, with the head office in Prague. The enterprise currently operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. It was established on April 07, 2008. It currently has a total number of 6 - 9 (2023) employees. The latest financial highlights indicate a net sales revenue increase of 4.59% in 2023. Its’ total assets recorded a growth of 10.46%. The net profit margin of Optimapharm S.R.O. increased by 8.01% in 2023.

Headquarters
Vaclavkova 519/4
Prague; The City of Prague; Postal Code: 16000

Contact Details: Purchase the Optimapharm S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Optimapharm S.R.O. report to view the information.
Outstanding Shares:
Purchase the Optimapharm S.R.O. report to view the information.
Registered Capital:
Purchase the Optimapharm S.R.O. report to view the information.
Incorporation Date:
April 07, 2008
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Optimapharm S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
4.59%
Total operating revenue
4.55%
Operating profit (EBIT)
41.73%
Net Profit (Loss) for the Period
5416.67%
Total assets
10.46%
Total equity
5.69%
Operating Profit Margin (ROS)
1.24%
Net Profit Margin
8.01%
Return on Equity (ROE)
5.28%
Quick Ratio
-0.92%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?